Invest in Bergen’s Post

🇳🇴🌟 LSX Nordic Congress is coming to Bergen in 2025!🌟 This is a milestone for Norway’s Health and Investment Ecosystem and a huge win for our region! I'm incredibly proud that UNCOMMON had the good fortune to collaborate with LSX and (many) other local ecosystem champions to attract such a high-caliber, international health investment event to our shores. This is soooo cool!! 😎 🤝 Far from just securing 'another event', this is the culmination of extensive bridge building and efforts by key local actors – all with the aligned goal of amplifying Bergen and Norway's role on the global stage, and positioning our region as a thriving hub for life sciences and healthcare innovation. The vision around getting LSX was clear from the start: ✅ Step 𝟭: Attract the event – along with 𝟱𝟬𝟬✚ investors, innovators, experts, strategic partners & customers ✅ Step 𝟮: Unify our local ecosystem – leveraging the event to align academia, business, and government to spark new collaborations ⏭️ Step 𝟯: Realise Long-Term Impact – unlock access to risk capital, talent & expertise --> accelerate innovation --> strengthen commercial ambitions across Norway's health & life sciences sectors --> realise success cases... and repeat... 🚀 In short, LSX and the ecosystem orbiting it, will bring immense value. Instead of reaching out to these crucial actors, they are coming to us! ⚡️ Next steps:   Locking in this event was only the beginning, we’re now actively engaging the entire ecosystem to fully capitalize on this unique opportunity and show the wider international community what Norway, and Bergen has to offer 💪 ‼️ We’re actively speaking with over 𝟮𝟬𝟬 individuals and organizations – so if we haven’t connected yet and should, please reach out. Or drop any suggestions in the comments. 🙏 Big thanks to Josh Dance, Matthew Pullan, LSX - partnering for Life Science eXecutives for recognizing the potential of Norway and the benefits of Bergen. And to Sverre Simen Hov, and Tom Morgan for the incredible support with this and your ongoing efforts to build value for the region. 👏 Well done to Farzad Abdi-Dezfuli and Sarsia for being the first local sponsors! 🙌 And this would not have happened without the initial enthusiasm of Bergen Næringsråd, Haraldsplass diakonale sykehus, Kjerstin Fyllingen (and all the Expert Gruppe Helse members), Alrek helseklynge, Berit Angelskår, Eitri, Ådne Iden Høiland, Tone Skår, Endre Adolfsen, Haukeland universitetssjukehus, Hege Rob Moi, Invest in Bergen, EY, Marthe Reinkind, Visit Bergen Official, Arve Lindgren, Peder Heggdal, Bettina Husebø S., VIS, Torleif Markussen Lunde, Youwell AS, Øyvind Grimsgaard, and numerous others ✚✚✚... I’m excited to see the impact unfold and look forward to sharing more about ways to get involved, as well as an initiative to help companies prepare for success with investors! 🚀 Details of the LSX Nordic Congress 2024 attendee list, and how to register for Bergen 2025 below!👇

✨ The LSX Nordic Congress is heading to Bergen We’re thrilled to announce that the LSX Nordic Congress is moving to Bergen, Norway next year! Mark your calendar for 20th - 21st May 2025, as we bring our gathering of life science leaders in Northern Europe to a new setting.   Why Norway? As a hub for life sciences, Norway offers a perfect blend of thriving innovation, global partnerships, and cutting-edge research – making it an ideal backdrop for the LSX Nordic Congress in 2025. Curious about who you’ll meet? - https://lnkd.in/eUnVXcnp Explore this year’s highlights for a snapshot of 2024’s attendee insights, from regional representation to industry expertise and seniority. You’ll also find a list of attending companies and a guide to investor interests and preferences.   Save Big by Planning Ahead! - https://lnkd.in/eRRJ88F2 Get ahead of the crowd and lock in your spot early – book by January 31 and save up to €650! Why wait? Secure your place now and make the most of this exclusive rate before prices go up. #LSXNordic #LifeScience #Biotech #Medtech #Healthtech #Investment #Partnership

This year's Nordic Congress is set to be a good one! We are expanding into the Baltics and still bringing international capital, partners and attention to these amazing countries to invest in innovation Fun fact, last year 38% of attendees were investors and 33% were Life Science and Healthcare executives. If you're a Nord-Baltic company looking to raise funds in 2024 or 25, I wouldn't think there's better place to be this October? #investment #nordic #baltic #pharma #biotech #medtech #techbio #lsxnordic

Check out APEX's Business Growth Tradeshow before you head to the Economic Growth Forum, it's the perfect segue! Business advice, workforce support, grant funding, and business accelerators all in one place! 💡

Our CEO, Stefan Kernstock, will join a panel of inspiring industry leaders at InLifeScience 2024 for the discussion "Life Science Export – A Culture for Nurturing Scaleups." Together with experts like Torsten Knüttel, Vice President of R&D at Gentian Diagnostics , and Mia Louise Kråkstad Healthcare Director at IQVIA Nordics, they will discuss how Norway can better support life science companies in scaling and thriving in global markets. The Life Science Cluster #LifeScience #InLifeScience2024 #MedicalDiagnostics #Scaleups #GlobalMarkets #NorwegianIndustry #GlobalMarkets #NorwegianIndustry

H3 Team Spotlight: Shaping the Future of Life Sciences at Global Conferences" Next week, a significant event will unfold in the life sciences industry – two of the most prominent conferences will take place, and we're thrilled to announce that the H3 team will be playing instrumental roles in both. This participation is not just about representation; it's about fostering global connections, facilitating growth, and powering advancement in the life sciences sector. One of our esteemed team members, Paul Field, will be attending BioTrinity in Europe. BioTrinity is not just an event; it's a crucial annual gathering that brings together the entire life sciences ecosystem. It is a platform where ideas meet opportunities, where novel relationships are forged, and where growing life sciences companies gain invaluable advice and support. Paul's presence at this event is a testament to our commitment to establishing relationships and facilitating dialogue in the industry. Across the globe in Singapore, the Asia Bio Partnering Forum will be in full swing. This annual conference is a melting pot of biotech and pharma leaders from every corner of the world. It's a platform where emerging innovators across the Asia-Pacific region connect and advance deal making. Representing the H3 team, Dr. Tam Nguyen will be at the forefront of these connections, contributing to the conversations that shape our industry's future. These conferences are more than just events; they are the pulse of the life sciences industry. They mark the convergence of the brightest minds, the most innovative solutions, and the most promising opportunities. As such, the H3 team's participation is a strategic move to be at the heart of these developments, to learn, share, and drive change. When Paul and Dr. Tam return from their respective conferences, they will bring back more than just insights and experiences. They will bring back new connections, potential collaborations, and opportunities for growth that will undoubtedly contribute to our company's ongoing success. We at H3 believe in the power of networking, the value of relationships, and the potential of collaboration. We are committed to actively participating in these industry events because they offer a unique opportunity to connect with peers, learn from experts, and contribute to the global conversation on life sciences. In closing, we are excited about the impact Paul and Dr. Tam will have at these conferences. But most importantly, we are excited about the potential these events hold for the future of life sciences, and we are proud to be a part of it. #lifesciences #collaboration #growth

EUCROF25 is not just a conference....... it is a crucial intersection of theory and practice, offering an extensive array of presentations, expert panel discussions, interactive workshops, and breakout sessions........ Join us from February 2-4, 2025, in the vibrant city of Copenhagen, Denmark, for the 2025 European Clinical Research Conference (EUCROF25). Following the resounding success of the EUCROF24 Conference in Prague, we are excited to continue this tradition, offering a dynamic platform for industry professionals to converge, collaborate, and catalyse advancements in clinical research. EUCROF24 set new records, with attendance surpassing 325 professionals from over 170 organisations and more than 25 countries, making it the largest and most diverse EUCROF conference to date. The high demand led to an early sell-out of exhibition and sponsorship opportunities, underscoring the critical role and enthusiasm within the clinical research community. Do not miss out on the opportunity to be part of EUCROF25 as a delegate, an exhibitor or a sponsor. Find out more here: https://lnkd.in/eQP39Kx3 Premier Sponsors: Medidata Solutions, EvidentIQ Dr. Martine Dehlinger-Kremer, Simon Lee, Martin O'Kane, Sverre Bengtsson, Benedikt Van Nieuwenhove, Alexandre Malouvier, Antonio Torres, Nicole Bohrmann, Fiona Maini, Cristina Florescu Moraid, Alan Yeomans, Nira Garty #clinicalresearch #clinicaltrials #GCP #EUCROF

Exciting news! The #TSANZConf in Melbourne is officially open. Follow The Transplantation Society of Australia and New Zealand's new LinkedIn page to stay updated on all the latest from this year's conference and #TSANZ news. Don’t miss out on groundbreaking research and insights! #TransplantationScience #MedicalInnovation #HealthcareTechnology #Conference2024 #MedicalResearch #Transplant #TransplantationResearch

September 26-27 is coming and #BioBridges2024 will have again exciting speakers and program. Should you wish to learn more visit us at biobridges.eu and get inspired also by our Archive section containing presentations from our past years 2016-2023. Last year was fun, with rich scientific content and relaxing networking dinner. #BioBridgesConference has covered: M13 guideline series: status update, Susana Almeida and Volodymyr Stus and Mary Malamatari Tmax/pAUCs, Jiri Hofmann and Tadalafil Tmax – case study, Paolo Biffignandi pAUCs and clinical relevance for LALA, Vit Perlik NTIs, Paulo Paixao Current thinking of a tailored clinical approach in biosimilars, Rene Anour Equivalence for lozenges: in vitro in vivo and link between both, Jean-Michel Cardot Detection of data manipulation in bioequivalence trials, Anders Fuglsang Sex– and group-related problems in BE – a delusion, Helmut Schutz Comparison and interpretation of dissolution time profiles of oral tablets, Stefan Horkovics-Kovats RWE – real world evidence/RWD real world data, Steffen Thirstrup and Mariusz Mogielnicki Well-established use – case studies, Jana Klimasova Hybrid as registration route for alternative formulations and posologies to increase patient comfort/adherence, Paula Muniz

🔬 𝗛𝗲𝗹𝗽 𝘀𝗵𝗮𝗽𝗲 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗦𝘄𝗲𝗱𝗶𝘀𝗵 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲! Last year, 200 companies took part in the Barometer survey, contributing valuable insights into the state of Swedish life science. The resulting report has become a key resource for Swedish decision-makers, as well as investors and executives in the industry both in Sweden and internationally. Now, it’s your turn! We invite senior management and leaders from life science companies and organizations—as well as those supporting the sector, like service providers and investors—to take this year’s survey. By dedicating just 10 minutes, you’ll be playing a part in building a more data-driven life science industry that benefits us all. 🔗 To the current survey: https://lnkd.in/dAgF7DY5 🔗 To the latest Barometer report: https://lnkd.in/drcrJQfq Produced by SwedenBIO in partnership with Medicon Village, Sahlgrenska Science Park, Stockholm Science City, STUNS and Citeline #LifeScience #Innovation